ASAnat Segev‐Becker

Anat Segev‐Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anat Segev‐Becker has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Asaf Oren

    Institute of Paediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children's Hospital, Tel Aviv, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel

    4 shared publications
  • Liat Perl

    The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky University Medical Center

    4 shared publications
  • Yael Lebenthal

    The Gray Faculty of Medical & Health Sciences, Tel Aviv University , Tel Aviv 6997801

    4 shared publications
  • Avivit Brener

    Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel, affiliated to The Gray Faculty of Medical & Health Sciences, Tel Aviv University , Tel Aviv, Israel

    3 shared publications
  • Tamar Sheppes

    The Institute of Pediatric Endocrinology, Diabetes and Metabolism, Dana‐Dwek Children's Hospital, Tel Aviv Sourasky Medical Center Tel‐Aviv Israel

    2 shared publications
  • Alexander Lowenthal

    Pediatric Cardiology Institute, Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center

    1 shared publication

Latest Publications

  • Open Access

    Autism Spectrum Disorder Among Gender‐Diverse Children and Adolescents: A National Cohort Study

    by Erez Topaz, Tamar Sheppes, Anat Segev‐Becker, Galit Israeli, Asaf Oren, Yael Lebenthal, Tomer Shechner, Liat Perl

    Autism spectrum disorder (ASD) is more prevalent in transgender and gender‐diverse (TGD) individuals than in the general population, yet the specific developmental pathways within and clinical outcomes of this intersection are insufficiently understood. This study examined how ASD and sex assigned at birth (SAAB) are associated with gender‐related milestones, access to gender‐affirming consultation and care (GACC), and psychiatric outcomes. We reviewed electronic medical records for 786 TGD children and adolescents (aged 4–19 years) presenting to a national referral clinic between 2013 and 2025. Demographic, developmental, and psychiatric variables were analyzed across four ASD‐by‐SAAB groups using generalized linear models and logistic regressions, with Bonferroni‐adjusted post hoc comparisons ( α = 0.0083). ASD was documented in 9.7% of the cohort, with referrals of autistic TGD patients increasing significantly over time. Autistic patients presented with a distinct profile, characterized by higher socioeconomic position (SEP), intellectual giftedness, non‐binary gender identity, and an earlier stage of pubertal development at presentation. Crucially, while ages at gender‐related milestones were largely comparable between neurotypes, autistic assigned female at birth (AFAB) adolescents were significantly less likely to initiate puberty suppression or gender‐affirming hormones than their non‐autistic peers. Furthermore, higher SEP was associated with earlier clinical presentation only for non‐autistic youth. Autistic TGD patients exhibited a higher psychiatric burden, with an ASD diagnosis uniquely associated with elevated rates of anxiety, ADHD, and psychotropic medication use. These findings reveal a disparity between developmental synchrony and clinical access, underscoring the need for autism‐informed protocols to support equitable gender‐affirming care.

  • Open Access

    Introduction of Somatrogon in Pediatric Growth Hormone Deficiency: Real-World Insights From a National Survey of Pediatric Endocrinologists

    by Eyal Cohen-Sela, Asaf Oren, Liat Perl, Ravit Regev, Anat Segev Becker, Ori Eyal, Kineret Mazor-Aronovitch, Ariel Tenenbaum, Marianna Rachmiel, Yael Lebenthal, et al.


  • QT interval changes in transgender/gender diverse adolescents receiving gonadotropin-releasing hormone agonist and gender-affirming hormonal treatment

    by Hussein Zaitoon, Livia Kapusta, Galit Israeli, Anat Segev-Becker, Gil Beer, Alexander Lowenthal, Gili Yaeger Yarom, Asaf Oren, Liat Perl

    The duration of the cardiac action potential is reflected by the QT interval, which is measured as the time between the start of the QRS complex and the end of the T wave on an electrocardiogram (E...


  • Open Access

    Body composition, metabolic syndrome, and lifestyle in treatment‐naïve gender‐diverse youth in Israel

    by Ophir Borger, Anat Segev‐Becker, Liat Perl, Asaf Ben Simon, Michal Yackobovitch‐Gavan, Tamar Sheppes, Avivit Brener, Asaf Oren, Yael Lebenthal

    Summary: Background: There is a scarcity of published studies evaluating transgender/gender‐diverse youth before initiating gender‐affirming hormones.Aim: To study the body composition, metabolic syndrome (MetS) components and lifestyle habits in treatment‐naïve transgender youth.Methods: Cross‐sectional study evaluating 153 transgender youth [median age 15.7 years, 94 transgender males] who attended The Israeli Children and Adolescents Gender Clinic between 6/2021–12/2022. Clinical, metabolic data and lifestyle habits (diet, physical activity and sleep patterns) were retrieved from the medical files. Body composition was determined by bioelectrical impedance analysis. Body mass index and muscle‐to‐fat ratio z‐scores were calculated by sex designated at birth.Results: Weight categories differed between genders, with a greater proportion of subjects classified as underweight among transgender females, and a greater proportion affected by overweight/obese/severe obese among transgender males (p = 0.035). The odds for MetS components were increased by 2.2 for every 1 standard deviation decrease in the muscle‐to‐fat ratio z‐score (95%CI: 1.45 to 3.26, p < 0.001). About one‐third of the cohort did not meet any of the three lifestyle recommendations. Transgender males had increased odds for MetS components by 3.49 (95%CI: 1.63 to 7.44, p = 0.001).Conclusions: Treatment‐naïve transgender‐male adolescents have an imbalance between muscle and adipose tissue, which places them at increased susceptibility for MetS components even prior to hormonal treatment.


  • Paediatricians' practices and knowledge of corticosteroids: A national survey

    by Opal Sekler, Anat Segev‐Becker, Hagar Interator, Avivit Brener, Anita Schachter‐Davidov, Erella Elkon‐Tamir, Yael Lebenthal

    Aim To explore corticosteroid prescription practices and knowledge among paediatricians. Methods The Paediatricians Corticosteroids Survey, a cross-sectional, web-based survey distributed to Israeli paediatricians between February and July 2018. Results Three hundred and forty-nine paediatricians (105 general paediatricians, 207 subspecialists and 37 paediatric endocrinologists) participated. Two hundred and three (58.2%) had >10 years of paediatric clinical experience and treated >60 patients/wk on average, 175/318 (55%) prescribed corticosteroids to >10% of their patients. On knowledge items, 11/266 (4.1%) responded 'not sure' when tapering of steroids is required, 22/268 (8.2%) to what 'stress dose' meant and 27/268 (10.1%) when a stress dose is required. Multivariate linear analysis showed higher scores were associated with training in paediatric endocrinology (beta = 2.271,P = 0.032); medical practice only in a subspecialty (beta = 1.909,P = 0.041) or in both general paediatrics and a subspecialty (beta = 2.023,P = 0.014), compared to general paediatrics alone and medical studies in Israel (beta = 1.059,P = 0.035). Overall, 96.2% thought continued medical education (CME) sessions would be helpful. Conclusion Our findings suggest that despite clinical experience with corticosteroid usage, respondents demonstrated gaps in knowledge for potentially life-threatening situations. Corticosteroid-based CME programs are warranted to improve paediatricians' knowledge and patient management.